SearchDictionaryMobileLogin

Glycogen Storage Disease Type IIb

23  relevant articles (0 outcomes, 1 trials/studies) found for this Disease

Description: An X-linked dominant multisystem disorder resulting in cardiomyopathy, myopathy and MENTAL RETARDATION. It is caused by mutation in the gene encoding LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 2.

Also Known As:
Danon Disease; Glycogen Storage Disease IIb; Vacuolar Cardiomyopathy and Myopathy, X-linked; X-Linked Vacuolar Cardiomyopathy and Myopathy; Disease, Danon; Vacuolar Cardiomyopathy and Myopathy, X linked; X Linked Vacuolar Cardiomyopathy and Myopathy

Disease Context: Research Results

Related Diseases

1. Muscular Diseases (Myopathy)
2. Glycogen Storage Disease (Glycogenosis)
3. Mental Retardation (Idiocy)
4. Cardiomyopathies (Cardiomyopathy)
5. Hypertrophic Cardiomyopathy (Asymmetric Septal Hypertrophy)

Experts

1. Charron, Philippe: 1 article (03/2006)
2. Echaniz-Laguna, Andoni: 1 article (03/2006)
3. Nishino, Ichizo: 1 article (03/2006)
4. Guiraud-Chaumeil, Christophe: 1 article (03/2006)
5. Richard, Pascale: 1 article (03/2006)
6. Tranchant, Christine: 1 article (03/2006)
7. Mohr, Michel: 1 article (03/2006)
8. Epailly, Eric: 1 article (03/2006)
9. Ohno, K: 1 article (01/2000)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Glycogen Storage Disease Type IIb:
1. alpha-Glucosidases (Acid Maltase)IBA
2. Lysosomal-Associated Membrane Protein 2IBA